Healthcare / Biopharmaceuticals

Digital Twins & Biosimulations

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER

What is Digital Twins & Biosimulations?

Companies in this market enable virtual trials by testing drugs digitally on simulated versions of living entities. Solutions predict trial outcomes based on a number of different approaches, from using real-world data to simulating human physiology.

Selling a product or service?
Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.

Claim your CB Insights Profile

Leaders

Leaders are the most established service providers in the market and possess the breadth to address various customer needs.

See why these companies made it as leaders for Digital Twins & Biosimulations. These companies include Standigm and GNS Healthcare.

Standigm logo
Standigm

South Korea / Founded Year: 2015

Standigm is an AI and systems biology-based startup that aims to expedite the drug discovery process. Standigm develops a computer modeling technology that learns medical and biological information and predicts the action mechanism of pharmaceutics in advance. This technology can improve the pharmaceutical development process by tailoring the application of previous know-hows, come up with possible combinations of pharmaceuticals, and optimize the selection of candidates and participants for clinical trials.

Known Partners

DeepMatter, Gartner, SK Chemicals, and 2 more

Key People

Sang Song, Jinhan Kim, Donggyun Kang, and 2 more

GNS Healthcare logo
GNS Healthcare

United States / Founded Year: 2000

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Known Customers

QIAGEN, Cigna Ventures

Key People

Colin Hill, Alan Kilyk, David Gascoigne, and 1 more

Unlearn logo
Unlearn

United States / Founded Year: 2017

Unlearn creates a machine learning (ML) platform for creating Intelligent Control Arms with Digital Twins. Unlearn is working closely with biopharma companies and regulators to ensure its methods meet scientific and regulatory standards.

Key People

Aaron Smith, Charles Fisher, Graham Siegel

Highfliers

Highfliers are the most innovative service providers in the market and possess the resources to address evolving customer needs.

See why these companies made it as highfliers for Digital Twins & Biosimulations. These companies include .

Outperformers

Outperformers are the most specialized service providers in the market and possess the expertise to address unique customer needs.

See why these companies made it as outperformers for Digital Twins & Biosimulations. These companies include .

Challengers

Challengers are the most promising service providers in the market and possess the agility to address emerging customer needs.

See why these companies made it as challengers for Digital Twins & Biosimulations. These companies include Novadiscovery and My Intelligent Machines.

Novadiscovery logo
Novadiscovery

France / Founded Year: 2010

Novadiscovery (Nova) is a health tech company using clinical trial simulation technology to predict drug efficacy and optimize clinical trial development. Nova combines mathematical models and artificial intelligence of diseases and drugs to simulate in silico clinical trials in virtual patient populations. The clinical trial simulation platform, Jinkō, helps biopharma companies by lowering cost of development, accelerating its pace and bringing drugs to market sooner.

Known Partners

Janssen, ENYO Pharma

Key People

Jean-Pierre Boissel, Francois-Henri Boissel, Gregoire Boutonnet, and 1 more

M
My Intelligent Machines

Canada / Founded Year: 2016

My Intelligent Machines is a platform as a service helping biologists analyze genomic data using AI. The platform finds the appropriate algorithms to analyze the user's data and generates text on its methods of analysis.

Key People

Sarah Jenna, Lucie Valois, Nicolas Bertrand, and 2 more

What is Digital Twins & Biosimulations?

Companies in this market enable virtual trials by testing drugs digitally on simulated versions of living entities. Solutions predict trial outcomes based on a number of different approaches, from using real-world data to simulating human physiology.

Selling a product or service?
Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.

Claim your CB Insights Profile